Prevalence and Risk Factors for Non-Vertebral Fractures in Patients Receiving Oral Glucocorticoids

Author(s):
Sosa-HenrIquez ManuelSosa-HenrIquez Manuel1,*, Gomez de Tejada-Romero Maria JesusGomez de Tejada-Romero Maria Jesus2, Saavedra-Santana PedroSaavedra-Santana Pedro2, Blazquez-Cabrera Jose AntonioBlazquez-Cabrera Jose Antonio2, Garcia-Vadillo Jess AlbertoGarcia-Vadillo Jess Alberto2, Valdes-Llorca CarmenValdes-Llorca Carmen2, Diaz-Curiel ManuelDiaz-Curiel Manuel2, Munoz-Torres ManuelMunoz-Torres Manuel2, Martinez-Rodriguez Maria ElenaMartinez-Rodriguez Maria Elena2, Navarro-Ceballos CarmenNavarro-Ceballos Carmen2, Sanfelix-Genoves JoseSanfelix-Genoves Jose2, Cancelo-Hidalgo Maria JesusCancelo-Hidalgo Maria Jesus2, Carpintero-Benitez PedroCarpintero-Benitez Pedro2, Mesa-Ramos ManuelMesa-Ramos Manuel2, Palacios-Gil AntunanoPalacios-Gil Antunano3
1Spanish Society for Investigation of Osteoporosis and Bone Metabolic Diseases (SEIOMM), Spain
2Spanish Society for Investigation of Osteoporosis and Bone Metabolic Diseases (SEIOMM), [email protected], Spain
3Santiago, International Society of Osteoporosis and Bone Mineral Metabolism (SIBOMM), Madrid

International Journal of Endocrinology and Metabolism:Vol. 10, issue 2; 480-485
Published online:Dec 01, 2012
Article type:Research Article
Received:Nov 07, 2011
Accepted:Mar 02, 2012
How to Cite:Manuel S, Jesus GDTM, Pedro S, Jose Antonio B, Alberto GJ, et al. Prevalence and Risk Factors for Non-Vertebral Fractures in Patients Receiving Oral Glucocorticoids. Int J Endocrinol Metab. 2012;10(2):. doi: https://doi.org/10.5812/ijem.3442

Abstract

Background:

Glucocorticoids taken orally increase the risk of fractures. It has been noted that a dose as low as 2.5 mg/day increases the risk of vertebral fracture. What is less clear is the possible influence of other risk factors for osteoporosis on the presence of non-vertebral fractures in patients taking glucocorticoids.

Objectives:

A cross-sectional study, performed on 513 men and women from Spain, who were taking at least 7.5 mg/day of oral prednisone for a minimum of 3 months. A questionnaire was developed, through which information on risk factors was collected.

Patients and Methods:

A cross-sectional study, performed on 513 men and women from Spain, who were taking at least 7.5 mg/day of oral prednisone for a minimum of 3 months. A questionnaire was developed, through which information on risk factors was collected.

Results:

28.3% of the patients who were taking glucocorticoids at a daily oral dose of 7.5 mg/day for a minimum of 3 months had suffered at least one non-vertebral fracture. The risk increased with age, the number of months the glucocorticoids had been taken, the presence of falls in the last year and, above all, with a maternal history of hip fracture.

Conclusions:

In patients taking oral glucocorticoids for over 3 months at doses higher than 7.5 mg/day of prednisone or equivalent, the prevalence of non-vertebral fractures was 28.3%. Some risk factors associated with the presence of these fractures were identified. The duration of glucocorticoid use appears to be more strongly related to the presence of non-vertebral fractures than the daily dose.

Full Text

Full text is available in PDF

Crossmark
Crossmark
Checking
Share on
Cited by
Metrics

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles